Share on StockTwits

Research analysts at Piper Jaffray increased their price objective on shares of DaVita HealthCare Partners (NYSE:DVA) from $73.00 to $76.00 in a report released on Friday, Stock Ratings Network reports. The firm currently has an “overweight” rating on the stock. Piper Jaffray’s price target would suggest a potential upside of 12.78% from the company’s current price.

A number of other analysts have also recently weighed in on DVA. Analysts at Ned Davis Research upgraded shares of DaVita HealthCare Partners from a “neutral” rating to a “buy” rating in a research note on Monday, April 21st. Separately, analysts at Citigroup Inc. reiterated a “neutral” rating on shares of DaVita HealthCare Partners in a research note on Thursday, April 17th. They now have a $71.00 price target on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of DaVita HealthCare Partners in a research note on Thursday, April 10th. They now have a $73.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $88.56.

DaVita HealthCare Partners (NYSE:DVA) opened at 67.39 on Friday. DaVita HealthCare Partners has a 1-year low of $52.75 and a 1-year high of $70.68. The stock’s 50-day moving average is $68.87 and its 200-day moving average is $63.82. The company has a market cap of $14.367 billion and a price-to-earnings ratio of 23.69.

DaVita HealthCare Partners (NYSE:DVA) last announced its earnings results on Thursday, May 1st. The company reported $0.85 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.86 by $0.01. The company had revenue of $3.04 billion for the quarter, compared to the consensus estimate of $3.02 billion. During the same quarter last year, the company posted $1.84 earnings per share. DaVita HealthCare Partners’s revenue was up 7.5% compared to the same quarter last year. On average, analysts predict that DaVita HealthCare Partners will post $3.70 earnings per share for the current fiscal year.

DaVita HealthCare Partners Inc, formerly DaVita Inc, is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (NYSE:DVA).

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.